Cover Image

Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial.

Blinding trachoma, caused by ocular infection with Chlamydia trachomatis, is targeted for global elimination by 2020. Knowledge of risk factors can help target control interventions.As part of a cluster randomised controlled trial, we assessed the baseline prevalence of, and risk factors for, active...

Full description

Saved in:

Bibliographic Details
Main Authors:	Emma M Harding-Esch (Author), Tansy Edwards (Author), Harran Mkocha (Author), Beatriz Munoz (Author), Martin J Holland (Author), Sarah E Burr (Author), Ansumana Sillah (Author), Charlotte A Gaydos (Author), Dianne Stare (Author), David C W Mabey (Author), Robin L Bailey (Author), Sheila K West (Author), PRET Partnership (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2010-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Non-participation during azithromycin mass treatment for trachoma in The Gambia: heterogeneity and risk factors.
by: Tansy Edwards, et al.
Published: (2014)

Mass treatment with azithromycin for trachoma control: participation clusters in households.
by: Elizabeth N Ssemanda, et al.
Published: (2010)

Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study.
by: Emma Harding-Esch, et al.
Published: (2015)

Association between ocular bacterial carriage and follicular trachoma following mass azithromycin distribution in The Gambia.
by: Sarah E Burr, et al.
Published: (2013)

Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
by: Emma M Harding-Esch, et al.
Published: (2013)

Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia.
by: Emma M. Harding-Esch, et al.
Published: (2013)

Cross-Sectional Surveys of the Prevalence of Follicular Trachoma and Trichiasis in The Gambia: Has Elimination Been Reached?
by: Sarah E Burr, et al.
Published: (2016)

A randomized trial of two coverage targets for mass treatment with azithromycin for trachoma.
by: Sheila K West, et al.
Published: (2013)

Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?
by: Emma M Harding-Esch, et al.
Published: (2009)

Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in the Gambia
by: Sarah E Burr, et al.

Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.
by: Matthew J Burton, et al.
Published: (2010)

Diagnostic accuracy of a prototype point-of-care test for ocular Chlamydia trachomatis under field conditions in The Gambia and Senegal.
by: Emma M Harding-Esch, et al.
Published: (2011)

Population-based prevalence survey of follicular trachoma and trachomatous trichiasis in the Casamance region of Senegal
by: Emma M. Harding-Esch, et al.
Published: (2017)

Evidence for contamination with C. trachomatis in the household environment of children with active Trachoma: A cross-sectional study in Kongwa, Tanzania.
by: Sheila K West, et al.
Published: (2019)

The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children.
by: Jennifer S Lee, et al.
Published: (2014)

Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-naïve trachoma-hyperendemic communities of the Bijagós Archipelago, Guinea Bissau.
by: Anna R Last, et al.
Published: (2014)

Serology, infection, and clinical trachoma as tools in prevalence surveys for re-emergence of trachoma in a formerly hyperendemic district.
by: Michelle Odonkor, et al.
Published: (2021)

Field evaluation of the Cepheid GeneXpert Chlamydia trachomatis assay for detection of infection in a trachoma endemic community in Tanzania.
by: Alexander Jenson, et al.
Published: (2013)

The "F" in SAFE: Reliability of assessing clean faces for trachoma control in the field.
by: Sheila K West, et al.
Published: (2017)

Exposure to an Indoor Cooking Fire and Risk of Trachoma in Children of Kongwa, Tanzania.
by: Andrea I Zambrano, et al.
Published: (2015)

Risk of seroconversion and seroreversion of antibodies to Chlamydia trachomatis pgp3 in a longitudinal cohort of children in a low trachoma prevalence district in Tanzania.
by: Xinyi Chen, et al.
Published: (2022)

Household willingness to pay for azithromycin treatment for trachoma control in the United Republic of Tanzania
by: Frick Kevin D., et al.
Published: (2003)

Azithromycin mass treatment for trachoma control: risk factors for non-participation of children in two treatment rounds.
by: Elizabeth N Ssemanda, et al.
Published: (2012)

CT694 and pgp3 as serological tools for monitoring trachoma programs.
by: E Brook Goodhew, et al.
Published: (2012)

Children as messengers of health knowledge? Impact of health promotion and water infrastructure in schools on facial cleanliness and trachoma in the community.
by: Xinyi Chen, et al.
Published: (2021)

A cross-sectional survey of water and clean faces in trachoma endemic communities in Tanzania
by: Kiboko Steven, et al.
Published: (2011)

Environmental factors and hygiene behaviors associated with facial cleanliness and trachoma in Kongwa, Tanzania.
by: Xinyi Chen, et al.
Published: (2021)

Environmental factors and hygiene behaviors associated with facial cleanliness and trachoma in Kongwa, Tanzania
by: Xinyi Chen, et al.
Published: (2021)

Gender differences in trachomatous scarring prevalence in a formerly trachoma hyperendemic district in Tanzania
by: Meraf A. Wolle, et al.
Published: (2024)

Gender differences in trachomatous scarring prevalence in a formerly trachoma hyperendemic district in Tanzania.
by: Meraf A Wolle, et al.
Published: (2024)

The distribution of ocular Chlamydia prevalence across Tanzanian communities where trachoma is declining.
by: Salman A Rahman, et al.
Published: (2015)

Risk factors for the progression of trachomatous scarring in a cohort of women in a trachoma low endemic district in Tanzania.
by: Meraf A Wolle, et al.
Published: (2021)

Risk factors for the progression of trachomatous scarring in a cohort of women in a trachoma low endemic district in Tanzania
by: Meraf A. Wolle, et al.
Published: (2021)

Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.
by: Fengchen Liu, et al.
Published: (2013)

Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
by: Chrissy H Roberts, et al.
Published: (2014)

Correction: The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining.
by: Salman A Rahman, et al.
Published: (2015)

Correction: Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity
by: Fengchen Liu, et al.
Published: (2013)

Correction: Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity.
by: Fengchen Liu, et al.
Published: (2013)

Comparison of two approaches to measuring clean faces as part of the facial cleanliness component of the SAFE trachoma elimination strategy.
by: Sheila K West, et al.
Published: (2024)

When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries.
by: Kathryn J Ray, et al.
Published: (2009)